Literature DB >> 28578872

An Atlas of β-Glucuronidases in the Human Intestinal Microbiome.

Rebecca M Pollet1, Emma H D'Agostino1, William G Walton1, Yongmei Xu2, Michael S Little1, Kristen A Biernat1, Samuel J Pellock1, Loraine M Patterson1, Benjamin C Creekmore1, Hanna N Isenberg1, Rohini R Bahethi1, Aadra P Bhatt1, Jian Liu2, Raad Z Gharaibeh3, Matthew R Redinbo4.   

Abstract

Microbiome-encoded β-glucuronidase (GUS) enzymes play important roles in human health by metabolizing drugs in the gastrointestinal (GI) tract. The numbers, types, and diversity of these proteins in the human GI microbiome, however, remain undefined. We present an atlas of GUS enzymes comprehensive for the Human Microbiome Project GI database. We identify 3,013 total and 279 unique microbiome-encoded GUS proteins clustered into six unique structural categories. We assign their taxonomy, assess cellular localization, reveal the inter-individual variability within the 139 individuals sampled, and discover 112 novel microbial GUS enzymes. A representative in vitro panel of the most common GUS proteins by read abundances highlights structural and functional variabilities within the family, including their differential processing of smaller glucuronides and larger carbohydrates. These data provide a sequencing-to-molecular roadmap for examining microbiome-encoded enzymes essential to human health.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Human Microbiome Project; X-ray crystallography; alpha-beta hydrolase; gastrointestinal microbiota; glycan metabolism

Mesh:

Substances:

Year:  2017        PMID: 28578872      PMCID: PMC5533298          DOI: 10.1016/j.str.2017.05.003

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  46 in total

1.  Dendroscope 3: an interactive tool for rooted phylogenetic trees and networks.

Authors:  Daniel H Huson; Celine Scornavacca
Journal:  Syst Biol       Date:  2012-07-10       Impact factor: 15.683

2.  Fast gapped-read alignment with Bowtie 2.

Authors:  Ben Langmead; Steven L Salzberg
Journal:  Nat Methods       Date:  2012-03-04       Impact factor: 28.547

3.  Alleviating cancer drug toxicity by inhibiting a bacterial enzyme.

Authors:  Bret D Wallace; Hongwei Wang; Kimberly T Lane; John E Scott; Jillian Orans; Ja Seol Koo; Madhukumar Venkatesh; Christian Jobin; Li-An Yeh; Sridhar Mani; Matthew R Redinbo
Journal:  Science       Date:  2010-11-05       Impact factor: 47.728

Review 4.  The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.

Authors:  P I Mackenzie; I S Owens; B Burchell; K W Bock; A Bairoch; A Bélanger; S Fournel-Gigleux; M Green; D W Hum; T Iyanagi; D Lancet; P Louisot; J Magdalou; J R Chowdhury; J K Ritter; H Schachter; T R Tephly; K F Tipton; D W Nebert
Journal:  Pharmacogenetics       Date:  1997-08

5.  Pharmacologic targeting of bacterial β-glucuronidase alleviates nonsteroidal anti-inflammatory drug-induced enteropathy in mice.

Authors:  Amanda LoGuidice; Bret D Wallace; Lauren Bendel; Matthew R Redinbo; Urs A Boelsterli
Journal:  J Pharmacol Exp Ther       Date:  2012-02-10       Impact factor: 4.030

Review 6.  Multiple NSAID-induced hits injure the small intestine: underlying mechanisms and novel strategies.

Authors:  Urs A Boelsterli; Matthew R Redinbo; Kyle S Saitta
Journal:  Toxicol Sci       Date:  2012-10-22       Impact factor: 4.849

7.  Ecological and physiological studies on large intestinal bacteria in relation to production of hydrolytic and reductive enzymes involved in formation of genotoxic metabolites.

Authors:  A J McBain; G T Macfarlane
Journal:  J Med Microbiol       Date:  1998-05       Impact factor: 2.472

8.  Molecular insights into microbial β-glucuronidase inhibition to abrogate CPT-11 toxicity.

Authors:  Adam B Roberts; Bret D Wallace; Madhu Kumar Venkatesh; Sridhar Mani; Matthew R Redinbo
Journal:  Mol Pharmacol       Date:  2013-05-20       Impact factor: 4.436

9.  SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information.

Authors:  Marco Biasini; Stefan Bienert; Andrew Waterhouse; Konstantin Arnold; Gabriel Studer; Tobias Schmidt; Florian Kiefer; Tiziano Gallo Cassarino; Martino Bertoni; Lorenza Bordoli; Torsten Schwede
Journal:  Nucleic Acids Res       Date:  2014-04-29       Impact factor: 16.971

10.  The Pfam protein families database: towards a more sustainable future.

Authors:  Robert D Finn; Penelope Coggill; Ruth Y Eberhardt; Sean R Eddy; Jaina Mistry; Alex L Mitchell; Simon C Potter; Marco Punta; Matloob Qureshi; Amaia Sangrador-Vegas; Gustavo A Salazar; John Tate; Alex Bateman
Journal:  Nucleic Acids Res       Date:  2015-12-15       Impact factor: 16.971

View more
  50 in total

1.  Pharmacological Activation of PXR and CAR Downregulates Distinct Bile Acid-Metabolizing Intestinal Bacteria and Alters Bile Acid Homeostasis.

Authors:  Joseph L Dempsey; Dongfang Wang; Gunseli Siginir; Qiang Fei; Daniel Raftery; Haiwei Gu; Julia Yue Cui
Journal:  Toxicol Sci       Date:  2019-03-01       Impact factor: 4.849

2.  Active site flexibility revealed in crystal structures of Parabacteroides merdae β-glucuronidase from the human gut microbiome.

Authors:  Michael S Little; Samantha M Ervin; William G Walton; Ashutosh Tripathy; Yongmei Xu; Jian Liu; Matthew R Redinbo
Journal:  Protein Sci       Date:  2018-10-27       Impact factor: 6.725

3.  Discovering the Microbial Enzymes Driving Drug Toxicity with Activity-Based Protein Profiling.

Authors:  Parth B Jariwala; Samuel J Pellock; Dennis Goldfarb; Erica W Cloer; Marta Artola; Joshua B Simpson; Aadra P Bhatt; William G Walton; Lee R Roberts; Michael B Major; Gideon J Davies; Herman S Overkleeft; Matthew R Redinbo
Journal:  ACS Chem Biol       Date:  2019-12-12       Impact factor: 5.100

Review 4.  Precision Medicine Goes Microscopic: Engineering the Microbiome to Improve Drug Outcomes.

Authors:  Kathy N Lam; Margaret Alexander; Peter J Turnbaugh
Journal:  Cell Host Microbe       Date:  2019-07-10       Impact factor: 21.023

5.  [Effectiveness of Saccharomyces boulardii combined with phototherapy in the treatment of hyperbilirubinemia in neonates: a prospective randomized controlled trial].

Authors:  Wei Tang; Hong-Yan Lu; Qin Sun; Wei-Min Xu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-11

6.  Discovery and Characterization of FMN-Binding β-Glucuronidases in the Human Gut Microbiome.

Authors:  Samuel J Pellock; William G Walton; Samantha M Ervin; Dariana Torres-Rivera; Benjamin C Creekmore; Grace Bergan; Zachary D Dunn; Bo Li; Ashutosh Tripathy; Matthew R Redinbo
Journal:  J Mol Biol       Date:  2019-01-15       Impact factor: 5.469

7.  A Probe-Enabled Approach for the Selective Isolation and Characterization of Functionally Active Subpopulations in the Gut Microbiome.

Authors:  Christopher Whidbey; Natalie C Sadler; Reji N Nair; Regan F Volk; Adrian J DeLeon; Lisa M Bramer; Sarah J Fansler; Joshua R Hansen; Anil K Shukla; Janet K Jansson; Brian D Thrall; Aaron T Wright
Journal:  J Am Chem Soc       Date:  2018-12-17       Impact factor: 15.419

8.  Structural basis for the regulation of β-glucuronidase expression by human gut Enterobacteriaceae.

Authors:  Michael S Little; Samuel J Pellock; William G Walton; Ashutosh Tripathy; Matthew R Redinbo
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-21       Impact factor: 11.205

Review 9.  Activity-based protein profiling in bacteria: Applications for identification of therapeutic targets and characterization of microbial communities.

Authors:  Laura J Keller; Brett M Babin; Markus Lakemeyer; Matthew Bogyo
Journal:  Curr Opin Chem Biol       Date:  2019-12-10       Impact factor: 8.822

10.  Three structurally and functionally distinct β-glucuronidases from the human gut microbe Bacteroides uniformis.

Authors:  Samuel J Pellock; William G Walton; Kristen A Biernat; Dariana Torres-Rivera; Benjamin C Creekmore; Yongmei Xu; Jian Liu; Ashutosh Tripathy; Lance J Stewart; Matthew R Redinbo
Journal:  J Biol Chem       Date:  2018-10-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.